Impact of GneXpert MTB/RIF on TB outcomes in an ART clinic

Not Applicable

• Conditions: HIV/AIDS; Tuberculosis

• Registration Number: PACTR201303000505764
• Lead Sponsor: Professor Peter Mason

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

aged 18 years or older
- HIV positive eligible for ART

Exclusion Criteria

- on ART
- on TB treatment/treated in the past 6 months
- seriously ill (fever >38oC, respiratory rate >30 beats/minute and unable to walk unaided)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adverse outcome

Secondary Outcome Measures

Name	Time	Method
-diagnostic yield of sputum induction ;Risk factors for adverse outcome;Burden of TB in asymptomatic patients